
CRISPR Therapeutics AG
CRSPHealthcare|Biotechnology|CH
$50.07
+1.51 (+3.11%)
Tangible Book / Share
$17.04
Cash / Share
$23.49
Ownership Breakdown
99.5%
Float
97.0M
Shares Outstanding
96.5M
Float Shares
Major Holders (6)
Combined: 43.8%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Catherine D. Wood | HC, IN | 11.79% | 11,313,623 | Apr 30, 2026 | 13D/G |
| ARK Investment Management LLC | Investment adviser | 11.79% | 11,313,623 | Apr 30, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 8.30% | 7,987,262 | Jul 27, 2026 | 13D/G |
| Orbis Investment Management LTD | Non-US institution | 5.60% | 5,433,344 | Aug 14, 2026 | 13D/G |
| Capital World Investors | Investment adviser | 5.10% | 4,929,428 | May 14, 2026 | 13D/G |
| Capital International Investors | Investment adviser | 1.20% | 1,186,794 | Feb 5, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,297,891 acquired · 702,941 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sakhamuri Sivakesava | Chief Technical Officer | Nov 4, 2026 | AWARD | 90,000 | $51.78 | $4.7M | Form 4 |
| Sakhamuri Sivakesava | Chief Technical Officer | Nov 4, 2026 | AWARD | 40,000 | — | — | Form 4 |
| Sakhamuri Sivakesava | Nov 2, 2026 | OTHER | 0 | — | — | Form 4 | |
| Silver Andrew Jacob | Chief Financial Officer | Oct 26, 2026 | AWARD | 18,000 | $49.01 | $882.2K | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 26, 2026 | AWARD | 9,000 | — | — | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Oct 26, 2026 | AWARD | 18,000 | $49.01 | $882.2K | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Oct 26, 2026 | AWARD | 9,000 | — | — | Form 4 |
| Kulkarni Samarth | director, officer: Chief Executive Officer | Oct 26, 2026 | AWARD | 57,500 | $49.01 | $2.8M | Form 4 |
| Kulkarni Samarth | director, officer: Chief Executive Officer | Oct 26, 2026 | AWARD | 28,750 | — | — | Form 4 |
| Patel Naimish | Chief Medical Officer | Oct 26, 2026 | AWARD | 24,000 | $49.01 | $1.2M | Form 4 |
| Patel Naimish | Chief Medical Officer | Oct 26, 2026 | AWARD | 12,000 | — | — | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 19, 2026 | AWARD | 25,000 | — | — | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 19, 2026 | OTHER | 4,892 | $35.59 | $174.1K | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 19, 2026 | OTHER | 1,395 | $39.00 | $54.4K | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 19, 2026 | OTHER | 2,805 | $44.67 | $125.3K | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 19, 2026 | OTHER | 1,800 | $86.75 | $156.2K | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 19, 2026 | OTHER | 4,522 | $133.88 | $605.4K | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 19, 2026 | OTHER | 1,966 | $97.00 | $190.7K | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 19, 2026 | OTHER | 3,840 | $58.29 | $223.8K | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 19, 2026 | OTHER | 2,366 | $61.65 | $145.9K | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 19, 2026 | OTHER | 8,431 | $43.22 | $364.4K | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 19, 2026 | OTHER | 3,766 | $44.31 | $166.9K | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 19, 2026 | OTHER | 9,039 | $72.94 | $659.3K | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 19, 2026 | OTHER | 3,766 | $49.00 | $184.5K | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 19, 2026 | OTHER | 18,734 | $42.12 | $789.1K | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 19, 2026 | OTHER | 6,944 | $67.74 | $470.4K | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 19, 2026 | OTHER | 14,874 | $46.24 | $687.8K | Form 4 |
| Silver Andrew Jacob | Chief Financial Officer | Oct 19, 2026 | OTHER | 10,000 | — | — | Form 4 |
| Kulkarni Samarth | director, officer: Chief Executive Officer | Oct 16, 2026 | OPTION EX. | 100,000 | — | — | Form 4 |
| Kulkarni Samarth | director, officer: Chief Executive Officer | Oct 19, 2026 | SELL | 47,837 | $49.78 | $2.4M | Form 4 |
| Kulkarni Samarth | director, officer: Chief Executive Officer | Oct 16, 2026 | OPTION EX. | 100,000 | — | — | Form 4 |
| George Simeon | director | Oct 14, 2026 | OPTION EX. | 30,000 | $14.00 | $420.0K | Form 4 |
| George Simeon | director | Oct 14, 2026 | SELL | 14,514 | $49.63 | $720.4K | Form 4 |
| George Simeon | director | Oct 14, 2026 | OPTION EX. | 30,000 | $14.00 | $420.0K | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Oct 13, 2026 | OPTION EX. | 2,113 | — | — | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Oct 14, 2026 | SELL | 1,040 | $49.26 | $51.2K | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Oct 13, 2026 | OPTION EX. | 2,113 | — | — | Form 4 |
| Kulkarni Samarth | director, officer: Chief Executive Officer | Oct 13, 2026 | OPTION EX. | 8,333 | — | — | Form 4 |
| Kulkarni Samarth | director, officer: Chief Executive Officer | Oct 14, 2026 | SELL | 4,098 | $49.26 | $201.9K | Form 4 |
| Kulkarni Samarth | director, officer: Chief Executive Officer | Oct 13, 2026 | OPTION EX. | 8,333 | — | — | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Oct 6, 2026 | OPTION EX. | 1,990 | $13.62 | $27.1K | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Oct 6, 2026 | SELL | 1,990 | $60.04 | $119.5K | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Oct 6, 2026 | OPTION EX. | 1,990 | $13.62 | $27.1K | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Sep 22, 2026 | OPTION EX. | 10,400 | $13.62 | $141.6K | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Sep 22, 2026 | SELL | 10,400 | $60.24 | $626.5K | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Sep 22, 2026 | OPTION EX. | 10,400 | $13.62 | $141.6K | Form 4 |
| Behbahani Ali | director | Sep 17, 2026 | OPTION EX. | 30,000 | $14.00 | $420.0K | Form 4 |
| Behbahani Ali | director | Sep 17, 2026 | SELL | 13,679 | $57.09 | $780.9K | Form 4 |
| Behbahani Ali | director | Sep 17, 2026 | OPTION EX. | 30,000 | $14.00 | $420.0K | Form 4 |
| Behbahani Ali | director | Aug 6, 2025 | J | 60 | — | — | Form 4 |
| Behbahani Ali | director | Aug 6, 2025 | J | 15 | — | — | Form 4 |
| Prasad Raju | Chief Financial Officer | Aug 7, 2026 | GIFT | 750 | — | — | Form 4 |
| George Simeon | director | Jun 5, 2026 | AWARD | 13,000 | $51.84 | $673.9K | Form 4 |
| Behbahani Ali | director | Jun 5, 2026 | AWARD | 13,000 | $51.84 | $673.9K | Form 4 |
| Fardis Maria | director | Jun 5, 2026 | AWARD | 13,000 | $51.84 | $673.9K | Form 4 |
| Fleming Harold Edward | director | Jun 5, 2026 | AWARD | 13,000 | $51.84 | $673.9K | Form 4 |
| Greene John | director | Jun 5, 2026 | AWARD | 13,000 | $51.84 | $673.9K | Form 4 |
| High Katherine A | director | Jun 5, 2026 | AWARD | 13,000 | $51.84 | $673.9K | Form 4 |
| Mahatme Sandesh | director | Jun 5, 2026 | AWARD | 13,000 | $51.84 | $673.9K | Form 4 |
| Morrison Briggs | director | Jun 5, 2026 | AWARD | 13,000 | $51.84 | $673.9K | Form 4 |
| Rommel Christian | director | Jun 5, 2026 | AWARD | 13,000 | $51.84 | $673.9K | Form 4 |
| Treco Douglas A | director | Jun 5, 2026 | AWARD | 13,000 | $51.84 | $673.9K | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | May 29, 2026 | AWARD | 17,000 | — | — | Form 4 |
| Patel Naimish | Chief Medical Officer | May 29, 2026 | AWARD | 22,000 | — | — | Form 4 |
| Prasad Raju | Chief Financial Officer | May 29, 2026 | AWARD | 19,500 | — | — | Form 4 |
| Patel Naimish | Chief Medical Officer | May 28, 2026 | OPTION EX. | 10,000 | — | — | Form 4 |
| Patel Naimish | Chief Medical Officer | May 28, 2026 | OPTION EX. | 10,000 | — | — | Form 4 |
| Patel Naimish | Chief Medical Officer | May 29, 2026 | SELL | 3,786 | $55.62 | $210.6K | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Mar 20, 2026 | OPTION EX. | 6,250 | — | — | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Mar 23, 2026 | SELL | 3,182 | $46.78 | $148.9K | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Mar 20, 2026 | AWARD | 38,499 | $46.24 | $1.8M | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Mar 20, 2026 | AWARD | 25,000 | — | — | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Mar 20, 2026 | OPTION EX. | 6,250 | — | — | Form 4 |
| Kulkarni Samarth | director, officer: Chief Executive Officer | Mar 20, 2026 | OPTION EX. | 19,687 | — | — | Form 4 |
| Kulkarni Samarth | director, officer: Chief Executive Officer | Mar 23, 2026 | SELL | 10,020 | $46.78 | $468.7K | Form 4 |
| Kulkarni Samarth | director, officer: Chief Executive Officer | Mar 20, 2026 | AWARD | 114,249 | $46.24 | $5.3M | Form 4 |
| Kulkarni Samarth | director, officer: Chief Executive Officer | Mar 20, 2026 | AWARD | 81,875 | — | — | Form 4 |
| Kulkarni Samarth | director, officer: Chief Executive Officer | Mar 20, 2026 | OPTION EX. | 19,687 | — | — | Form 4 |
| Prasad Raju | Chief Financial Officer | Mar 20, 2026 | AWARD | 38,499 | $46.24 | $1.8M | Form 4 |
| Prasad Raju | Chief Financial Officer | Mar 20, 2026 | AWARD | 27,500 | — | — | Form 4 |
| Prasad Raju | Chief Financial Officer | Mar 20, 2026 | OPTION EX. | 6,250 | — | — | Form 4 |
| Prasad Raju | Chief Financial Officer | Mar 23, 2026 | SELL | 3,708 | $46.78 | $173.5K | Form 4 |
| Prasad Raju | Chief Financial Officer | Mar 20, 2026 | OPTION EX. | 6,250 | — | — | Form 4 |
| Patel Naimish | Chief Medical Officer | Mar 20, 2026 | AWARD | 38,499 | $46.24 | $1.8M | Form 4 |
| Patel Naimish | Chief Medical Officer | Mar 20, 2026 | AWARD | 30,000 | — | — | Form 4 |
| Patel Naimish | Chief Medical Officer | Mar 14, 2026 | OPTION EX. | 8,125 | — | — | Form 4 |
| Patel Naimish | Chief Medical Officer | Mar 14, 2026 | OPTION EX. | 8,125 | — | — | Form 4 |
| Patel Naimish | Chief Medical Officer | Mar 16, 2026 | SELL | 3,150 | $48.26 | $152.0K | Form 4 |
| Prasad Raju | Chief Financial Officer | Mar 14, 2026 | OPTION EX. | 6,875 | — | — | Form 4 |
| Prasad Raju | Chief Financial Officer | Mar 14, 2026 | OPTION EX. | 6,875 | — | — | Form 4 |
| Prasad Raju | Chief Financial Officer | Mar 16, 2026 | SELL | 5,848 | $48.26 | $282.2K | Form 4 |
| Prasad Raju | Chief Financial Officer | Mar 14, 2026 | OPTION EX. | 10,000 | — | — | Form 4 |
| Prasad Raju | Chief Financial Officer | Mar 16, 2026 | SELL | 4,021 | $48.26 | $194.1K | Form 4 |
| Prasad Raju | Chief Financial Officer | Mar 16, 2026 | GIFT | 750 | — | — | Form 4 |
| Prasad Raju | Chief Financial Officer | Mar 14, 2026 | OPTION EX. | 10,000 | — | — | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Mar 14, 2026 | OPTION EX. | 6,875 | — | — | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Mar 16, 2026 | SELL | 3,450 | $48.26 | $166.5K | Form 4 |
| KASINGER JAMES R. | General Counsel and Secretary | Mar 14, 2026 | OPTION EX. | 6,875 | — | — | Form 4 |
| Kulkarni Samarth | director, officer: Chief Executive Officer | Mar 14, 2026 | OPTION EX. | 20,625 | — | — | Form 4 |
| Kulkarni Samarth | director, officer: Chief Executive Officer | Mar 16, 2026 | SELL | 10,349 | $48.26 | $499.4K | Form 4 |
Congress & Senate Trades (7)
Thomas SuozziHouse · NY03Sep 20, 2021
Thomas SuozziHouse · NY03Jun 3, 2021
Marjorie Taylor GreeneHouse · GA14Jan 21, 2021
James Mountain InhofeSenate · OKJan 5, 2021
James Mountain InhofeSenate · OKDec 22, 2020
James Mountain InhofeSenate · OKJun 19, 2018
James Mountain InhofeSenate · OKOct 19, 2017